The All Wales Medicines Strategy Group started the assessment of ivacaftor (Kalydeco) as soon as the drug company formally engaged with the appraisal process. This process is recognised to be robust and normally takes about 21 weeks to allow all parties, including patient organisations such as the Cystic Fibrosis Trust, to submit their comments. The final appraisal decision for Kalydeco is scheduled to be reached at a public meeting on 8th May 2013.
More top news
Most of us will have a pleasant and dry evening with a few late sunny spells, though the odd light shower is possible.
The Eisteddfod's intention to visit an area must be proclaimed at least a year and a day before the beginning of the festival.
Roberts guided Robin McBryde's charges to a 19-17 comeback win in Apia as Steffan Evans popped up with two crucial second-half tries.